The decision clears the drug as a monotherapy for adults with unresectable, locally advanced or metastatic non-small cell lung cancer
AAV vectors are widely used in gene therapy for their strong therapeutic potential
The decision marks a key step in the centralized EU review process
Clearance marks major shift beyond chemotherapy
No approved vaccine or specific treatment currently available for Bundibugyo strain Ebola disease
The company is also highlighting early-stage innovation in antibody-drug conjugates and in vivo CAR-T therapy
The company said the breadth of its showcase reflects “progress from its differentiated oncology pipeline in solid tumors and hematologic malignancies,”
With standout ADC and t-cell engager response data across hard-to-treat cancers
Across more than 85 abstracts, AstraZeneca will showcase 10 approved medicines and 13 potential new therapies
Highlights strong Vibegron results in older men & real-world prostate cancer insights
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
